EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Pliant Therapeutics, Inc. (PLRX) EBIT Margin data is not available for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-23.58M |
|
-- |
|
-- |
|
$23.58M |
|
$-23.58M |
|
$0.00M |
|
$-23.58M |
|
$-23.58M |
|
$-23.58M |
|
$-23.58M |
|
$-23.58M |
|
$-23.58M |
|
$-23.58M |
|
$-22.93M |
|
61.37M |
|
61.37M |
|
$-0.37 |
|
$-0.37 |
|
| Balance Sheet Financials | |
$196.45M |
|
$2.94M |
|
$28.78M |
|
$225.23M |
|
$16.36M |
|
-- |
|
$27.66M |
|
$44.02M |
|
$181.21M |
|
$181.21M |
|
$181.21M |
|
61.45M |
|
| Cash Flow Statement Financials | |
$-128.34M |
|
$134.29M |
|
$-31.70M |
|
$72.67M |
|
$46.93M |
|
$-25.74M |
|
$26.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
EBIT Margin |
-- |
-- |
|
-- |
|
-- |
|
$-128.56M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.01% |
|
-13.01% |
|
-10.47% |
|
-13.01% |
|
$2.95 |
|
$-2.09 |
|
$-2.09 |
|